| Identification | Back Directory | [Name]
[2,2'-Bi-6,14-ethenomorphinan]-7,7'-dimethanol,17,17'-bis(cyclopropylmethyl)-a,a'-bis(1,1-dimethylethyl)-4,5:4',5'-diepoxy-18,18',19,19'-tetrahydro-3,3'-dihydroxy-6,6'-dimethoxy-a,a'-dimethyl-, (aS,5a,7a)-(a'S,5'a,7'a)- (9CI) | [CAS]
163597-04-4 | [Synonyms]
Pseudo Buprenorphine
2,2''-Bibuprenorphine
Buprenorphine IMpurity G
IIKJUPFUFVJKHV-BFVCJTJTSA-N
17,17′-di(cyclopropylmethyl)-4,5α
Pseudo Buprenorphine (1.0mg/ml in THF)
4′,5α′-diepoxy-7α,7α′-di[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6,6′-dimethoxy-2,2′-bi(6α,14-ethano-14α-morphinan)-3,3′-diol (2,2′-bibuprenorphine)
[5α,7α(S)]-[5'α,7'α(S)]-17,17'-Bis(cyclopropylMethyl)-α,α'-bis(1,1-diMethylethyl)-4,5:4',5'-diepoxy-18,18',19,19'-tetrahydro-3,3'-dihydroxy-6,6'-diMethoxy-α,α'-diMethyl-[2,2'-bi-6,14-ethenoMorphinan]-7,7'-diMethanol
(αS,5α,7α)-(α'S,5'α,7'α)-17,17'-Bis(cyclopropylMethyl)-α,α'-bis(1,1-diMethylethyl)-4,5:4',5'-diepoxy-18,18',19,19'-tetrahydro-3,3'-dihydroxy-6,6'-diMethoxy-α,α'-diMethyl-[2,2'-bi-6,14-ethenoMorphinan]-7,7'-diMethanol
[2,2'-Bi-6,14-ethenomorphinan]-7,7'-dimethanol, 17,17'-bis(cyclopropylmethyl)-α,α'-bis(1,1-dimethylethyl)-4,5:4',5'-diepoxy-18,18',19,19'-tetrahydro-3,3'-dihydroxy-6,6'-dimethoxy-α,α'-dimethyl-, (αS,5α,7α)-(α'S,5'α,7'α)-
[2,2'-Bi-6,14-ethenomorphinan]-7,7'-dimethanol,17,17'-bis(cyclopropylmethyl)-a,a'-bis(1,1-dimethylethyl)-4,5:4',5'-diepoxy-18,18',19,19'-tetrahydro-3,3'-dihydroxy-6,6'-dimethoxy-a,a'-dimethyl-, (aS,5a,7a)-(a'S,5'a,7'a)- (9CI) | [Molecular Formula]
C58H80N2O8 | [MOL File]
163597-04-4.mol | [Molecular Weight]
933.26 |
| Chemical Properties | Back Directory | [density ]
1.34±0.1 g/cm3(Predicted) | [solubility ]
Chloroform (Slightly), THF (Slightly) | [form ]
Solid | [pka]
8.49±0.60(Predicted) | [color ]
White to Yellow | [Stability:]
Light Sensitive |
|
|